Practical Approaches on CD30 Detection and Reporting in Lymphoma Diagnosis

Mina L. Xu(Yale Cancer Center), Alejandro A. Gru(University of Virginia), Mohamed E. Salama(The University of Texas at San Antonio Health Science Center), Ali Gabali(Wayne State University), Yuri Fedoriw(University of North Carolina at Chapel Hill), Radhakrishnan Ramchandren(The Christie NHS Foundation Trust), Mark R. Wick(University of Minnesota), Dennis P. O’Malley(Ambry Genetics (United States)), Kiran Vij(Washington University in St. Louis), Maxime Battistella(Peter MacCallum Cancer Centre), Eric D. Hsi(Mayo Clinic)
The American Journal of Surgical Pathology
September 26, 2019
10.1097/pas.0000000000001368
Cited by 25

Related Papers

The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee
|Blood|2022|1.5k
MYC/BCL2 protein coexpression contributes to the inferior survival of activated B-cell subtype of diffuse large B-cell lymphoma and demonstrates high-risk gene expression signatures: a report from The International DLBCL Rituximab-CHOP Consortium Program
|Blood|2013|683
MYC Drives Progression of Small Cell Lung Cancer to a Variant Neuroendocrine Subtype with Vulnerability to Aurora Kinase Inhibition
|Cancer Cell|2017|619
Spectrum of Epithelial Neoplasms in End-Stage Renal Disease
|The American Journal of Surgical Pathology|2006|484
A genetic mechanism for Tibetan high-altitude adaptation
|Nature Genetics|2014|441